1. Market Research
  2. > Pathology
92 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Global Chemotherapy Drugs Market - Opportunities and Forecast (2013-2023)

  • $ 2200
  • March 2019
  • 200 pages

Lymphoma Gastrointestine Others Figure ##: Types of cancer for which clinical trials using chemotherapy drugs treatment are being conducted ##% ##% ##% ##% ##% ##% ##% ##% ##% ##% ##% ##% ##% ##% ##% Source: U. S Clinical Trials Registry GLOBAL THERAPEUTIC CHEMOTHERAPY DRUGS MARKET FIGURE ##: GLOBAL

  • Cancer
  • Chemotherapy
  • Lymphoma
  • Therapy
  • Sanofi S.A.

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H1 2020

  • $ 2000
  • April 2020
  • 403 pages

It is in Phase I stage of development for diffuse large B cell lymphoma and high-grade B cell lymphoma.

  • Lung Cancer
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Sanofi S.A.

Global Regenerative Medicine Market - Opportunities and Forecast

  • $ 2400
  • August 2019
  • 326 pages

This strategic acquisition will further promote Gilead as an industry leader in refractory large B-cell lymphoma after two or more lines of therapy.

  • Biopharmaceutical
  • Lymphoma
  • Regenerative Medicine
  • Market Size
  • Sanofi S.A.

Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • August 2019
  • 228 pages

So the CAR T, for example, represents a cure of lymphoma and leukemia.

  • Blood Disease
  • Lymphoma
  • Pathology
  • Therapy
  • Sanofi S.A.

Global Sterile Injectables Market – Analysis By Molecule Type, Drug Type, Indication, Distribution Channel, By Region, By Country (2018 Edition): Forecast to 2023 - Molecule Type, Drug Type, Indication, Channel

  • $ 2400
  • June 2018
  • 240 pages

lymphoma Diffuse large B-cell lymphoma Diffuse large B-cell lymphoma Pfizer Utomilumab Human IgG## CD## Phase ## Hoffmann-La Roche Polatuzumab vedotin Humanized IgG## ADC CD##b Phase ## Viventia Bio Oportuzumab monatox Humanized scFv immunotoxin EpCAM Phase ## Bladder cancer S

  • Endocrine Disease
  • Lymphoma
  • World
  • Baxter International Inc.
  • Sanofi S.A.

Rheumatoid Arthritis: Global Drug Forecast and Market Analysis to 2027

  • $ 10995
  • January 2019
  • 201 pages

ALTHOUGH CELLTRION' S TRUXIMA WAS SIMILARLY TREATED BY THE FDA, THE COMPANY COMPLIED WITH REQUESTS FOR ADDITIONAL DATA AND IN NOVEMBER 2018, CELLTRION' S TRUXIMA WAS APPROVED, BUT ONLY FOR THE TREATMENT OF B-CELL NON-HODGKIN AND FOLLICULAR LYMPHOMAS (CELLTRION, PRESS RELEASE, ## NOV

  • Biosimilar
  • Hospital
  • Lymphoma
  • Therapy
  • Sanofi S.A.

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam

  • $ 1995
  • September 2019
  • 109 pages

It also discontinued GSK-## in Phase I stage of development for follicular lymphoma, diffuse large Bcell lymphoma, solid tumor, and refractory multiple myeloma.

  • Healthcare
  • Lymphoma
  • Pharmaceutical
  • Vietnam
  • Sanofi S.A.

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Spain

  • $ 1995
  • May 2019
  • 130 pages

Leading Market Position: Product Recall: GSK discontinued the global development of GSK-## in Phase I stage of development for relapsed or refractory small-cell lung cancer, as well as the development of GSK-## in Phase I stage of development for follicular lymphoma, diffuse large

  • Lymphoma
  • Medical Equipment
  • Pharmaceutical
  • Spain
  • Sanofi S.A.

Global Gene Therapy Market Report - 2026

  • $ 3849
  • July 2018
  • 105 pages

Lymphoma, B-Cell Lymphoma Cd##+ Diffuse Large B-Cell Lymphoma Undisclosed (Expected Oncology) Prostate Cancer, Lung Cancer Phase ## CTL## CAR-T Phase ##I BiTE platform CAR-T Phase ## LADD iMultiple Myelomauno-oncology platform Up to ## gene therapies including S##A## Phase ##

  • Gene Therapy
  • Lymphoma
  • Therapy
  • Boehringer Ingelheim GmbH
  • Sanofi S.A.

Nanotechnology in Medicine - Thematic Research

  • $ 1950
  • June 2020
  • 28 pages

Nanotechnology in Medicine Thematic Research: Medical Nanotechnology in Medicine is on the Rise A persistent problem in medicine is the ability to specifically target diseased cells and tissues.

  • Lymphoma
  • Pharmaceutical
  • Janssen Biotech, Inc.
  • Sanofi S.A.
  • Takeda Pharmaceutical Company Limited

Pharmaceutical Drugs Market Global Briefing 2018

  • $ 1000
  • January 2018
  • 46 pages

For example, in 2017, Kite Pharma' s CAT-T cell therapy, under clinical trial, showed results of increased life expectancy of terminally ill lymphoma patients by ## months after a single treatment. lxiii lxii Musculoskeletal Drugs had the third highest CAGR of ##. ##% during 2013-2017; this

  • Lymphoma
  • Pharmaceutical
  • World
  • Novartis AG
  • Sanofi S.A.

Global Injectable Drugs Market 2017-2021

  • $ 2500
  • July 2017
  • 84 pages

In January 2017, the FDA approved IMBRUVICA as the first treatment for relapsed/ refractory marginal zone lymphoma.

  • Lymphoma
  • Pathology
  • AbbVie Inc.
  • F. Hoffmann-La Roche Ltd.
  • Sanofi S.A.

Artificial Intelligence Technologies: Market Prospects - Featuring Expert Panel Views from Industry Survey 2018

  • $ 2995
  • March 2018
  • 104 pages

Artificial Intelligence Technologies: Market Prospects - Featuring Expert Panel Views from Industry Survey 2018 Summary Artificial intelligence (AI) is defined as the theoretical and practical application ...

  • Advanced IT
  • Artificial Intelligence
  • Healthcare
  • Pharmaceutical
  • Sanofi S.A.

Global Genetic Disorders Drugs Market to 2023 - A Rapidly Growing Treatment Landscape Driven by Targeted Complement System Inhibitors and Enzyme Replacement Therapies to Treat PNH and Lysosomal Storage Disease

  • $ 4995
  • December 2017
  • 160 pages

They also have an increased risk of Parkinson' s disease, and cancers such as myeloma, leukemia and lymphoma.

  • Clinical Trial
  • Genetic Disorder
  • Lymphoma
  • Therapy
  • Sanofi S.A.

Pharmaceutical Drugs Global Market Report 2018

  • $ 8000
  • March 2018
  • 455 pages

Its importance results from the large population of cancer patients suffering from various types of blood cancers such as leukemia, lymphoma, and myeloma.

  • Healthcare
  • Lymphoma
  • Pharmaceutical
  • Market Size
  • Sanofi S.A.

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Greece

  • $ 1995
  • November 2017
  • 149 pages

FOR EXAMPLE, IT DISCONTINUED SAR-##, WHICH WAS IN PHASE I TRIALS FOR THE TREATMENT OF ADVANCED SOLID TUMORS OR LYMPHOMAS, METASTATIC BRAF-MUTATED MELANOMA AND PTEN-DEFICIENT TUMORS, IN FEBRUARY 2015.

  • Healthcare
  • Hospital
  • Lymphoma
  • Pharmaceutical
  • Sanofi S.A.

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Egypt

  • $ 1995
  • December 2017
  • 133 pages

It is estimated that over ##, ## people are diagnosed with follicular lymphoma annually worldwide.

  • Lymphoma
  • Pharmaceutical
  • Egypt
  • North Africa
  • Sanofi S.A.

Global Diabetes Drugs Market to 2023 - A Diversifying Treatment Landscape as GLP-1 Receptor Agonists and SGLT-2 Inhibitors Gain Ground Following Landmark Cardiac Outcomes

  • $ 4995
  • September 2017
  • 137 pages

Numerous intracellular substrates such as insulin receptor substrate (IRS) proteins, casitas B-lineage lymphoma (CBL), adapter proteins with a pleckstrin homology (PH) and Src Homology ## (SH##) domain and GRB##-associated-binding protein ## (GAB##) are activated upon binding of the insulin rece

  • Clinical Trial
  • Diabetes
  • Insulin
  • Lymphoma
  • Sanofi S.A.

Global Antibody Drug Conjugates Market – Analysis By Drugs , Pipeline Drugs, Regulations: Opportunities and Forecasts - By Region ; By Country

  • $ 1800
  • March 2017
  • 154 pages

ACCORDING TO LYMPHOMA RESEARCH FOUNDATION THERE WERE AROUND ## PATIENTS SUFFERING FROM HODGKIN' S LYMPHOMA IN US.

  • Cancer
  • Lymphoma
  • Pharmaceutical
  • World
  • Sanofi S.A.

Monoclonal Antibodies - Global Trends in the Competitive, Technological and R&D Landscape

  • $ 2995
  • October 2017
  • 57 pages

For example, Rituxan is currently used against cancers involving the immune system (leukemias and lymphomas) and inflammatory diseases such as rheumatoid arthritis.

  • Lymphoma
  • Medical Biotechnology
  • Monoclonal Antibody
  • AbbVie Inc.
  • Sanofi S.A.
View report >

Vaccine Market in the US - Forecast, Monthly Update

  • June 2020
  • 16 pages

lymphoma Closed $##. ## billion deal of The Medicines Co., with new drug for elevated LDL-C - ## - GLAXOSMITHKLINE PLC (GSK: BUY) Products/ processes fighting COVID-## Earnings Expected to Rise LSD over next two years " Company' s primary aim is to develop multiple adjuvanted COVI

  • Lymphoma
  • Vaccine
  • United States
  • AstraZeneca PLC
  • Sanofi S.A.

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on